Delighted to share this study led by Dr. med. Inka Ristow, MHBA, Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations. Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement These findings emphasize the critical role of technology in optimizing oncological response evaluation. Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
Frederic Siepmann’s Post
More Relevant Posts
-
Delighted to share this study led by Dr. med. Inka Ristow, MHBA, Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations. Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement These findings emphasize the critical role of technology in optimizing oncological response evaluation. Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
-
-
Structured radiology reporting with mint Lesion™ automates guideline-compliant case assessment, rapid follow-ups, and optimal communication with referring physicians and sponsors for data-driven cancer care.
Delighted to share this study led by Dr. med. Inka Ristow, MHBA, Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations. Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement These findings underscore the critical role of technology in optimizing oncological response evaluation. Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
-
-
Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations. Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement These findings emphasize the critical role of technology in optimizing oncological response evaluation. Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
-
-
Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations. Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement These findings emphasize the critical role of technology in optimizing oncological response evaluation. Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
-
-
Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at Universitätsklinikum Hamburg Eppendorf! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations. Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement These findings emphasize the critical role of technology in optimizing oncological response evaluation. Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
-
-
Delighted to share this study led by @Inka Ristow, @Markus Sauer and their dedicated team at @UKE Hamburg! Their research underscores how software-assisted assessments, like #mintLesion™, help improve oncological patient care by elevating iRECIST-guided CT scan evaluations. Benefits of using #mintLesion™? 🕒 Expedited reading times 🔍 Fewer errors 🤝 Improved inter-reader agreement These findings emphasize the critical role of technology in optimizing oncological response evaluation. Want to read more about the study? Follow this link: https://bit.ly/3vvhQ6T #OncologyResearch #iRECIST #HealthcareInnovation #StructuredReporting
-
-
In flight to Boston for Personalized Medicine Coalition's annual conference! Looking forward to some great conversations on all things personalized medicine. If you're attending, let's find a time to connect! Below are some of the sessions I'm most looking forward to: 🌟 Investing in Diagnostics - While #therapeutics often gets the hype, it's been my perspective that diagnostics holds much of the power in changing health outcomes 🌟 Transforming Standard-of-Care Imaging into Precision Diagnostics - not biased, I promise 👀 Megan Nacar 🌟 Early Detection and the Future of Cancer Care - We've seen lots of developments, both highs and lows, this year for #EDx. Looking forward to hearing the latest perspectives
Who's headed to the Annual Personalized Medicine Conference in Boston next week? We’re excited to participate in this year’s conference on November 13-14, where leaders from across the personalized medicine landscape will converge to tackle some of the most pressing challenges facing the field today. Connect with our team at the conference, including Megan Nacar and Tina Wang. Don’t miss Megan on her panel, "Transforming Standard-of-Care Imaging into Precision Diagnostics," Wednesday, November 13, at 12:30 PM. Moderated by Quibim CEO Ángel Alberich-Bayarri, the discussion will explore advancements in imaging technologies driving the future of patient care. Every year this conference brings together a powerful mix of perspectives, from CEOs and clinicians to journalists and patient advocates. It’s a space for open exchange, ambitious thinking, and practical collaboration to accelerate the promise of personalized medicine. Attending the meeting or in Boston that week? Let’s connect! #PrecisionMedicine #BostonLifeSciences
-
-
With the development and approval of new treatments along with rapid technological changes in the practice of medicine, #ALS care is changing at a pace never seen before. Join us at ALS Nexus to learn more about the changing landscape and the future of ALS. Read More: https://lnkd.in/eJvUNgq4
-
📣 Brinc Portfolio News The CEO of Strados Labs, Nick Delmonico, has been featured in the April edition of Applied Clinical Trials Magazine, shedding light on the critical role of integrating subjective and objective measures in respiratory trials! 🔬 In the article, Nick discusses how leveraging technology can provide drug developers with invaluable insights and evidence, ultimately advancing the field of respiratory medicine. 🔍 Dive deeper to this topic and read the full feature here: bit.ly/4dkMZec #Brinc #BrincVC #BrincPortfolioNews #BrincHealthInnovation #HealthInnovation #Healthcare #RespiratoryTrials #Technology #VentureAccelerator #Innovation
CEO & Founder of Strados Labs, Nick Delmonico, was featured on Applied Clinical Trials Magazine
-
It's #ClinicalTrialsDay in the USA! Let's celebrate the heroes of medical progress who work tirelessly to change outcomes for patients worldwide. Clinical trials are the engines driving innovation in healthcare. They allow us to test new treatments and therapies, paving the way for a healthier future for all. Today, we recognize the incredible dedication of the brilliant researchers who design and oversee these trials, and the participants who give the ultimate gift to patients. 👀 Have you seen our list of #radiotherapeutics under clinical development? At the foundation, we are committed to sharing the status of radiotherapeutic molecules from their early stages. Check it out here: https://buff.ly/3Xr8Sjc #CancerResearch #CancerAwareness
-
